Previous studies have reported that AREG expression is upregulated by estrogen both in vitro and in vivo, and that high AREG expression is more prevalent in human ER+ breast cancers than ER- breast cancers [43–46], suggesting that AREG upregulation may be associated with increased ER+ breast cancer risk. Here, AREG is linked to breast cancer.